Popular topics
Where the capital lands, who writes the cheque, and what gets built with it. Funding rounds, venture capital flows, and the deal-making that shapes which technology companies scale.
6,932 articles · Funding
Paris-based Robeauté, a medtech startup focused on neurosurgical microrobots, has raised $28M (approximately €27.28M) in funding led by Plural, Cherry Ventures, and Kindred Ventures.
Eindhoven-based PHOTON IP, a manufacturer of advanced low-power optical chips, announced that it has secured €4.75M seed round led by Innovation Industries.
Leiden-based BIMINI Biotech, a drug development company focused on therapeutics for haematological cancers, closed a €3M seed investment round.
On Monday, Delaware, US-based Open.cx, the next-generation AI customer support platform, announced that it has raised $1.52M (approximately €1.48M) in a pre-seed funding round.
Technology is ever-evolving, and in this fast-paced world, it’s challenging to cover every story.
Horw, Switzerland-based CeQur, a medical device company dedicated to simplifying mealtime insulin delivery for individuals, announced that it has secured $120M (approximately €116.4M) in the financing round.
Oxford Cancer Analytics (OXcan), a UK-based medtech company that develops blood tests for early cancer detection using proteomics and AI…
Amsterdam-based Leyden Labs, a platform working to free people from the threat of respiratory viruses, announced Thursday that it has raised $70M (approximately €68M) in funding.
Amsterdam-based uniQure, a biotechnology company specialising in human gene-based therapies, recently announced its public offering of 4,411,764 ordinary shares at $17.00 per share.
Finland-based Hycamite, a company that produces low-carbon hydrogen and carbon products by splitting methane, announced that it has secured €44M in a two-step series A investment from strategic and financial investors.
On Thursday, Wien, Austria-based HelloBello, a pet tech company that offers freshly cooked, individually tailored meals, announced that it has secured €4M in a Series A funding round.
On Thursday, London-based Verdiva Bio Limited, a clinical-stage biopharmaceutical company, announced its launch to focus on developing innovative therapies for obesity and other cardiometabolic disorders.
